The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The CCK-B receptor: A novel target for therapy of hepatocellular carcinoma.
 
Aiwu Ruth He
Consulting or Advisory Role - Eisai; Genentech/Roche; Merck
Speakers' Bureau - bms; Eisai; Exelixis
Research Funding - Genentech; Merck
 
Martha D Gay
No Relationships to Disclose
 
Hong Cao
No Relationships to Disclose
 
Wenqiang Chen
No Relationships to Disclose
 
Bhaskar Kallakury
No Relationships to Disclose
 
Jill P Smith
Stock and Other Ownership Interests - Statera Biopharma
Consulting or Advisory Role - Clinical & Translational Research
Research Funding - AACR (Inst); Cancer Advances (Inst); Department of Defense (Inst); Harrington Discovery Institute (Inst); NCI (Inst); Ruesch Family Foundation (Inst)
Patents, Royalties, Other Intellectual Property - 10 issue patents, 2 licensed to Clinical & Translational research, 2 licensed to Stratera Biopharma, Some belong to Penn State University and some belong to Georgetown University